Plain-English translation of NCT07244835 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-in-human study testing a new medication called to treat advanced solid cancers. The study happens in two phases: first, researchers will give increasing doses to patients to find the safest dose, and then they'll test that dose in larger groups of patients with specific cancer types.
Many patients with advanced cancers run out of treatment options when standard therapies stop working. This study aims to develop a new treatment option for these patients by testing whether this medication can safely and effectively fight cancer.
You likely qualify if…
You likely don't qualify if…
You would take the study medication as a capsule by mouth once daily in 28-day cycles. In the first phase of the study, the dose will gradually increase to find the safest level; in the second phase, you would receive the established safe dose. You'll have regular visits with the research team to check your health, measure your tumor, and monitor for side effects.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China